High-dose radiotherapy plus prolonged hormone therapy in CT2-3 prostatic carcinoma: is it useful?
Cellini N, Pompei L, Fortuna G, Ammaturo MV, De Paula U, Luzi S, Mattiucci GC, Morganti AG, Digesù C, Rosetto ME, Palloni T, Petrongari MG, Gentile P, Deodato F, Valentini V.
Cellini N, et al. Among authors: luzi s.
Tumori. 2004 Mar-Apr;90(2):201-7. doi: 10.1177/030089160409000208.
Tumori. 2004.
PMID: 15237583
Clinical Trial.